Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-20Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
-
CLINICAL_TRIALS study record update · 2026-02-19A Randomized, Blinded, Controlled Phase I Clinical Trial to Evaluate the Safety of a Quadrivalent Subunit Influenza Vaccine (Adjuvant) in Adults Aged 65 Years and Older
-
CLINICAL_TRIALS study record update · 2026-02-19A Multicenter, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of the Investigational Product Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.
-
CLINICAL_TRIALS study record update · 2026-02-19A Randomized, Blinded, Controlled Phase I Clinical Trial to Evaluate the Safety of a Subunit Influenza Vaccine (Adjuvant) in Adults Aged 65 Years and Older
-
CLINICAL_TRIALS study record update · 2026-02-18Lower Respiratory Tract Infections Managed in Primary Care: A 10-year Nationwide Real-World Data Warehouse Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-11Efficacy of Combination Baloxovir and Oseltamivir Therapy in Influenza Infected Immunocompromised Hosts
-
CLINICAL_TRIALS study record update · 2026-02-10CSP #2038 - COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System (COPE-VA)
-
CLINICAL_TRIALS study record update · 2026-01-28A Phase Ⅲ, Randomized, Double-blind, Positive Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of an Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
-
CLINICAL_TRIALS study record update · 2026-01-28Randomized Controlled Trial of Different Behavioral Text Messages to Improve Influenza Vaccination Rates
-
CLINICAL_TRIALS study record update · 2026-01-26A PHASE 1/2 RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
-
CLINICAL_TRIALS study record update · 2026-01-22Effect of Oral Supplement Intervention on Influenza Vaccine Long-term Efficacy: a Follow-up Study
-
CLINICAL_TRIALS study record update · 2026-01-22Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection
-
CLINICAL_TRIALS study record update · 2026-01-21Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
-
CLINICAL_TRIALS study record update · 2026-01-20An Embedded Adaptive Randomized Controlled Trial of Corticosteroid Therapy for Severe Influenza Community-Acquired Pneumonia in Adults
-
CLINICAL_TRIALS study record update · 2026-01-16A Single-Center, Randomized, Blinded Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Vaccine (BK-01 Adjuvant) in Populations Aged 18 Years and Older
-
CLINICAL_TRIALS study record update · 2026-01-15A Randomized, Double-blind, Active-controlled Phase Ⅱ Clinical Trial to Evaluate the Immunogenicity and Safety of the Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
-
CLINICAL_TRIALS study record update · 2026-01-14A Randomized, Double-blind, Controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
-
CLINICAL_TRIALS study record update · 2026-01-09Randomized, Double-Blind, Phase 2 Study to Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03® or MF59®
-
CLINICAL_TRIALS study record update · 2026-01-06VRC 326 (001614): A Phase I Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
-
CLINICAL_TRIALS study record update · 2026-01-06An Observational Pharmacokinetic Study of Intravenous Voriconazole Used for Treatment of Invasive Aspergillosis in Adult Patients With Severe Influenza / COVID-19 Supported With Extra-corporeal Membrane Oxygenation (ECMO)
-
CLINICAL_TRIALS study record update · 2026-01-02Immunogenicity and Safety of a Quadrivalent Influenza Virus Subunit Vaccine in Subjects Aged 6-35 Months : A Randomized, Double-blind, Active-controlled Phase III Trial
-
CLINICAL_TRIALS study record update · 2026-01-02Phase 3 Double Blind Clinical Study of Effectiveness and Safety of Vero Cell-Derived, Trivalent, Seasonal Influenza Vaccine in Adults Aged 50 Years and Older
-
CLINICAL_TRIALS study record update · 2025-12-24Efficacy, Immunogenicity, and Safety of High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 1/2, Randomized, Observer-blind, Active-Control Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-based Influenza and SARS-CoV-2 Multi-component Vaccines in Healthy Adults
-
CLINICAL_TRIALS study record update · 2025-12-19Incidence of Symptomatic and Asymptomatic Influenza Among Healthcare Workers : A Multicenter Cohort Study